NW500 Non-Mydriatic Retinal Camera Clinical Performance Study
NCT ID: NCT05286502
Last Updated: 2022-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2022-03-01
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retinal Fundus Camera Evaluation
NCT02293174
Topcon 3D OCT-1000 Optical Coherence Tomography System
NCT00792259
Evaluation of the Signal to Noise Ratio at Various Retinal Layers
NCT02982174
An Age-Stratified Data Collection Study to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II
NCT01027936
Evaluation of a Digital Visual Acuity Device vs. Standard Visual Acuity Measurements
NCT06431295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults 18 years old or older
fundus photography
color fundus photography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fundus photography
color fundus photography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who are able to understand the written informed consent and are willing to participate as evidenced by signing the informed consent.
Exclusion Criteria
* Subjects with poor fixation or ocular media not sufficiently clear to obtain acceptable images.
* Subjects who cannot follow instructions to complete the required testing.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Topcon Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Topcon Healthcare Solutions
Oakland, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
THS-TPCN-2022-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.